Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last days
Enjoy this offer
* See conditions under "Our services"

Valuation: Kamada Ltd.

Market Cap 124.54Cr 0 42Cr 36Cr 34Cr 32Cr 59Cr 4.03TCr 60Cr 401.17Cr 155.32Cr 1.94TCr 157.82Cr 154.42Cr 6.75TCr P/E Ratio 2026 *
-
P/E Ratio 2027 * -
Enterprise Value 124.54Cr 0 42Cr 36Cr 34Cr 32Cr 59Cr 4.03TCr 60Cr 401.17Cr 155.32Cr 1.94TCr 157.82Cr 154.42Cr 6.75TCr EV / Sales 2026 *
2.13x
EV / Sales 2027 * 1.94x
Free-Float
54.51%
Yield 2026 *
-
Yield 2027 * -
1 day+0.74%
1 week+0.83%
Current month-1.76%
1 month-11.22%
3 months-20.82%
6 months-4.23%
Current year-3.76%
1 week 2,093
Extreme 2093
2,208
1 month 2,093
Extreme 2093
2,497
Current year 2,093
Extreme 2093
2,890
1 year 1,956
Extreme 1956
2,890
3 years 1,685
Extreme 1685
3,045
5 years 1,309
Extreme 1309
3,045
10 years 1,309
Extreme 1309
4,500
Manager TitleAgeSince
Chief Executive Officer 57 01/07/2015
Director of Finance/CFO 55 31/12/2017
Chief Operating Officer 53 01/11/2016
Director TitleAgeSince
Director/Board Member 75 13/12/1990
Chairman 77 07/03/2013
Chairman 55 12/08/2020
Date Insider Type Main position Quantity % Market Cap.
07/04Free

Director

32,000 0.0555%
07/04Free

Chief Executive Officer

16,00,000 2.7738%
07/04Free

Chief Financial Officer

4,05,000 0.7021%
Change 5-day change 1-year change 3-year change Capi.($)
+0.74%+0.83%-11.08%+13.99% 42Cr
+1.63%-2.74%+17.91%-18.09% 6.22TCr
+0.92%+4.67%+67.04%+221.49% 5.94TCr
-0.92%+28.60%+28.60%+28.60% 3.89TCr
+0.26%+9.80%-55.40%-65.15% 3.64TCr
+2.94%+1.79%+50.28%-35.26% 2.95TCr
+2.32%+6.51%+56.62%+76.65% 2.15TCr
+7.94%-3.78%+78.88%-59.73% 1.97TCr
+4.80%-0.20%-5.33%+112.95% 1.62TCr
-1.03%-2.78%+48.09%+99.17% 1.59TCr
Average +1.95%+1.44%+27.56%+37.46% 3TCr
Weighted average by Cap. +1.59%+1.87%+30.40%+45.39%

Financials

2026 *2027 *
Net sales 58Cr 0 20Cr 17Cr 16Cr 15Cr 28Cr 1.89TCr 28Cr 188.35Cr 73Cr 911.03Cr 74Cr 73Cr 3.17TCr 64Cr 0 22Cr 19Cr 17Cr 16Cr 30Cr 2.07TCr 31Cr 206.75Cr 80Cr 1TCr 81Cr 80Cr 3.48TCr
Net income 7.2Cr 0 2.43Cr 2.11Cr 1.94Cr 1.82Cr 3.4Cr 232.76Cr 3.48Cr 23Cr 8.98Cr 112.2Cr 9.13Cr 8.93Cr 390.11Cr 10Cr 0 3.5Cr 3.04Cr 2.8Cr 2.62Cr 4.9Cr 334.99Cr 5Cr 33Cr 13Cr 161.48Cr 13Cr 13Cr 561.46Cr
Net Debt - -
Logo Kamada Ltd.
Kamada Ltd is Israel based company, focused on plasma-derived protein therapeutics with a commercial product portfolio and a late-stage product pipeline. The Company uses its proprietary platform technology and know-how for the extraction and purification of proteins from human plasma to produce Alpha-1 Antitrypsin (AAT) in a highly-purified, liquid form, as well as other plasma-derived Immune globulins.
Employees
462
Date Price Change Volume
12/26/12 2,175.00 ILa +0.74% 11,810
11/26/11 2,159.00 ILa +0.61% 45,595
10/26/10 2,146.00 ILa 0.00% 27,942
09/26/09 2,146.00 ILa -0.09% 24,910
08/26/08 2,148.00 ILa -0.42% 36,219
Trader
-
Investor
-
Global
-
Quality
ESG MSCI
-

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. KMDA Stock
- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!